These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 235399)
21. The use of beta-adrenergic blockers in the treatment of angina and hypertension. A clinical symposium. 31st annual meeting, American College of Angiology and 21st annual meeting, International College of Angiology. San Antonio, Texas, November 6, 1984. Angiology; 1986 Mar; 37(3 Pt 2):215-62. PubMed ID: 2871778 [No Abstract] [Full Text] [Related]
22. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I]. Marmo E; Caputi AP; Saini RK Clin Ter; 1972 Jul; 62(1):11-51. PubMed ID: 4403671 [No Abstract] [Full Text] [Related]
29. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol]. Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742 [TBL] [Abstract][Full Text] [Related]
30. Comparative review of beta-blocking agents. Jackson EA; Sullman SA Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648 [No Abstract] [Full Text] [Related]
31. [Beta-adrenergic receptor blockers in clinical practice]. Czuriga I; Edes I Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106 [TBL] [Abstract][Full Text] [Related]
32. Which beta-blocker? Med Lett Drugs Ther; 2001 Feb; 43(1097):9-11. PubMed ID: 11177223 [No Abstract] [Full Text] [Related]
33. [Beta blocker therapy. New aspects--outdated opinions. Interview by G. Riecker]. Werdan K Internist (Berl); 1992 Sep; 33(9):618-21. PubMed ID: 1356943 [No Abstract] [Full Text] [Related]
34. [Our experience on the clinical use of nadolol]. Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492 [No Abstract] [Full Text] [Related]
35. How medical therapy of angina pectoris differs in patients over 65. Turi Z; Cohn PF Geriatrics; 1980 Dec; 35(12):26-34. PubMed ID: 6107260 [No Abstract] [Full Text] [Related]
36. [A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris]. Burkart F; Stamm G; Witassek F Schweiz Med Wochenschr; 1989 May; 119(18):575-81. PubMed ID: 2568685 [TBL] [Abstract][Full Text] [Related]
37. The role of beta-blockers as a cornerstone of cardiovascular therapy. Hollenberg NK Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194 [TBL] [Abstract][Full Text] [Related]
38. [Beta-blocking agents in the treatment of angina pectoris]. Lund-Larsen PG Tidsskr Nor Laegeforen; 1972 Feb; 92(5):355-7. PubMed ID: 4401368 [No Abstract] [Full Text] [Related]
39. The use of beta-adrenergic blockers in the treatment of angina and hypertension. Caris TN Angiology; 1986 Mar; 37(3 Pt 2):215-7. PubMed ID: 2871779 [TBL] [Abstract][Full Text] [Related]
40. Current status of beta adrenergic blockers. Kaul U; Wahi PL Indian J Chest Dis Allied Sci; 1980; 22(1):1-3. PubMed ID: 6111531 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]